Illumina (ILMN) Q1 Earnings Report Preview: What To Look For [Yahoo! Finance]
West Pharmaceutical Services, Inc. (WST)
Last west pharmaceutical services, inc. earnings: 4/23 06:00 am
Check Earnings Report
US:NYSE Investor Relations:
investor.westpharma.com
Company Research
Source: Yahoo! Finance
Illumina beat analysts' revenue expectations last quarter, reporting revenues of $1.16 billion, up 5% year on year. It was an exceptional quarter for the company, with full-year revenue guidance exceeding analysts' expectations and an impressive beat of analysts' organic revenue estimates. Is Illumina a buy or sell going into earnings? Read our full analysis here, it's free for active Edge members This quarter, the market is expecting Illumina's revenue to grow 2.9% year on year, a reversal from the 1.4% decrease it recorded in the same quarter last year. Illumina Total Revenue Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Illumina rarely misses Wall Street's revenue estimates. Looking at Illumina's peers in the life sciences tools & services segment, some have already reported their Q1 results, giving us a hint as to what we can expect. West P
Show less
Read more
Impact Snapshot
Event Time:
WST
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
WST alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
WST alerts
High impacting West Pharmaceutical Services, Inc. news events
Weekly update
A roundup of the hottest topics
WST
News
- West Pharmaceutical Services (WST) was upgraded by <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a> from "hold (c-)" to "hold (c)".MarketBeat
- West to Participate in Upcoming Investor Conferences [TheStreet.com]TheStreet.com
- West to Participate in Upcoming Investor ConferencesPR Newswire
- West Pharmaceutical Services (WST) was given a new $315.00 price target by Morgan Stanley.MarketBeat
- West Pharmaceutical Services (WST) was given a new $310.00 price target by Barclays PLC.MarketBeat
WST
Earnings
- 4/23/26 - Beat
WST
Sec Filings
- 4/29/26 - Form SCHEDULE
- 4/29/26 - Form 4
- 4/29/26 - Form 4
- WST's page on the SEC website